As consumers, we interact with encapsulated products all the time, be it the flavourings in our food, medicines we take, fragrances in our toiletries or materials used in our cars. To date, the challenge has been in finding a way to trigger encapsulation systems to release their cargo when the customer needs them – such as the release of stain-removing enzymes from a biological washing detergent in low temperature loads.
It is this unique proprietary capability that University spin-out Aqdot’s platform technology delivers. The company specialises in developing and commercialising disruptive encapsulation technologies that enable valuable actives (cargos) to be protected, delivered and released when required.
This game-changing approach enables Aqdot’s customers to increase product effectiveness, introduce novel and differentiated brands, reduce manufacturing costs and positively impact the environment.
The technology was developed at the University’s Department of Chemistry, through the collaboration of senior academics in Professor Chris Abell and Dr Oren Scherman’s teams. Both Abell and Scherman are members of Aqdot’s Scientific Advisory Board.
Aqdot is now engaged with customers across a number of sectors. Initially the company is focusing on household products, fragrances and niche industrial applications. Future potential applications include agrochemicals and pharmaceuticals.
Aqdot recently completed a £5m series A funding round led by Imperial Innovations alongside Parkwalk Advisors, Cambridge Enterprise, the commercialisation arm of the University of Cambridge and Providence Investment Company.Tags: aqdot, chemistry, chris abell, encapsulation, funding, Oren Scherman